ispor 17th annual international meeting financial disclosure information for research presentations

9
ISPOR 17TH ANNUAL INTERNATIONAL MEETING FINANCIAL DISCLOSURE INFORMATION FOR RESEARCH PRESENTATIONS The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose financial support for their research. The following financial support was declared: Reference Code Financial Support Reference Code Financial Support CE1 None CE2 None CE3 National Pharmaceutical Council, Washington, DC, USA CE4 None CN1 Healthcare and Social Agency, Emilia-Romagna Region, Italy CN2 Abbott Laboratories, Abbott Park, IL, USA CN3 American Cancer Society, Atlanta, GA, USA CN4 Bayer HealthCare Pharmaceuticals, Pine Brook, NJ, USA CO1 None CO2 None CO3 Agency for Healthcare Research and Quality, Rockville, MD, USA CO4 GlaxoSmithKline Biologicals, Rixensart, Belgium CV1 None CV2 Kantar Health, Princeton, NJ, USA CV3 None CV4 None DR1 None DR2 None DR3 Canadian Institutes of Health Research, Ottawa, ON, Canada DR4 National Pharmaceutical Council, Washington, DC, USA HC1 None HC2 Sunovion Pharmaceuticals, Inc., Marlborough, MA, USA HC3 None HC4 None IN1 None IN2 Bristol-Myers Squibb Company, Plainsboro, NJ, USA IN3 GlaxoSmithKline Biologicals, Wavre, Belgium IN4 Pfizer Inc., Collegeville, PA, USA MA1 Eli Lilly & Co., Indianapolis, IN, USA MA2 Janssen Scientific Affairs, LLC, Horsham, PA, USA MA3 Eli Lilly and Company, Indianapolis, IN, USA MA4 Sanofi-Aventis U.S., Bridgewater, NJ, USA ME1 None ME2 None ME3 National Cancer Institute, Bethesda, MD, USA ME4 Paradigm Spine, LLC, New York, NY, USA MO1 None MO2 Genentech, Inc., South San Francisco, CA, USA MO3 Agency for Healthcare Research and Quality, Rockville, MD, USA MO4 None PCN1 None PCN2 West Virginia University CoHORTS Centre, Morgantown, WV, USA PCN3 American Cancer Society, Atlanta, GA, USA PCN4 American Cancer Society, Atlanta, GA, USA PCN5 None PCN6 None PCN7 None PCN8 None PCN9 F. Hoffmann-La Roche Pharmaceuticals AG, Basle, Switzerland PCN10 Pfizer, São Paulo, Brazil PCN11 Bayer Healthcare, Wayne, NJ, USA PCN12 Bayer Healthcare, Wayne, NJ, USA PCN13 None PCN14 None PCN15 Bayer Healthcare, Wayne, NJ, USA PCN16 Bristol-Myers Squibb, Princeton, NJ, USA PCN17 Bayer Healthcare, Wayne, NJ, USA PCN18 None PCN19 None PCN20 None PCN21 None PCN23 None PCN24 Productos Roche S.A, Bogotá D.C, Colombia PCN25 American Cancer Society, Atlanta , GA, USA PCN26 Pliva Croatia Ltd., Zagreb, Croatia PCN27 Novartis, East Hanover, NJ, USA PCN28 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA PCN29 CPP - Customized Premium Products, S.A. de C.V, Mexico City, Mexico PCN30 None PCN31 United Medical, São Paulo, Brazil PCN32 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA PCN33 Eli Lilly and Company, Indianapolis, IN, USA PCN34 None PCN35 Janssen Scientific Affairs, LLC, Horsham, PA, USA PCN36 Janssen Scientific Affairs, LLC, Horsham, PA, USA PCN37 F. Hoffmann-La Roche Pharmaceuticals AG, Basle, Switzerland PCN38 None PCN39 Abbott Laboratories, Abbott Park, IL, USA PCN40 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA PCN41 GlaxoSmithKline, Philadelphia, PA, USA PCN42 None PCN43 None PCN44 Eisai, Inc., Woodcliff Lake, NJ, USA PCN45 Roche Polska Sp. z o.o., Warsaw, Poland PCN46 None PCN47 Bayer Healthcare, Wayne, NJ, USA PCN48 GSK, Rio de Janeiro, Brazil PCN49 Bristol-Myers Squibb, Plainsboro, NJ, USA PCN50 Genzyme, Toronto, ON, Canada PCN51 Bayer HealthCare Pharmaceuticals, Pine Brook, NJ, USA PCN52 Janssen-Cilag, Sao Paulo, Brazil PCN53 Bayer Healthcare, Wayne, NJ, USA PCN54 Bayer HealthCare Pharmaceuticals, Pine Brook, NJ, USA PCN55 Bayer Healthcare, Wayne, NJ, USA PCN56 None PCN57 Novartis, Hong Kong, China PCN58 None PCN59 GSK, Rio de Janeiro, Brazil PCN60 Novartis Oncology Colombia, Bogota D.C, Colombia PCN61 Pfizer, Mexico City, Mexico PCN62 Pfizer SAS, Bogota, Colombia PCN63 Universidad Nacional de Colombia, Bogotá, Colombia PCN64 None PCN65 Janssen Cilag, Bogota, Colombia PCN66 Janssen-Cilag AB, Sollentuna, Sweden PCN67 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA PCN68 Glaxo Smith Kline, Bogota, Colombia PCN69 None PCN70 GlaxoSmithKline, Mexico City, Mexico PCN71 Pierre-Fabre Farma de MMéexico, S.A. De C.V., MMéexico DF, Mexico PCN72 None PCN73 Pfizer S.A. de C.V., Ciudad de MMéexico, Mexico PCN74 Novartis, Mexico, Mexico PCN75 None PCN76 None PCN77 None PCN78 None PCN79 None PCN80 Phizer, Moscow, Russia PCN81 Roche Products Ltd., Taipei, Taiwan PCN82 None PCN83 Celgene Corporation, Summit, NJ, USA PCN84 None PCN85 None PCN86 None PCN87 None PCN88 Genzyme, Mississauga, ON, Canada PCN89 None PCN91 None PCN92 Celgene Inc., Mississauga, ON, Canada PCN93 None PCN94 None PCN95 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA PCN96 Bristol-Myers Squibb, Wallingford, CT, USA PCN97 Abbott Laboratories, Abbott Park, IL, USA PCN98 National Health and Medical Research Council, Canberra, Australia PCN99 Centers for Disease Control and Prevention, Atlanta, GA, USA PCN100 National Science Council, Taipei, Taiwan PCN102 Eli Lilly and Company, Indianapolis, IN, USA PCN103 Celgene Corporation, Summit, NJ, USA PCN104 Amgen, Thousand Oaks, CA, USA PCN105 Bayer HealthCare Pharmaceuticals, Wayne, NJ, USA PCN106 Center for Medical Technology Policy, Baltimore, MD, USA PCN107 Janssen Scientific Services, LLC, Horsham, PA, USA PCN108 Abbott, Abbott Park, IL, USA PCN109 Incyte Corporation, Wilmington, DE, USA PCN110 Boehringer Ingelheim International GmbH, Ingelheim, Germany PCN111 Celgene Corporation, Summit, NJ, USA A257 VALUE IN HEALTH 15 (2012) A257–A265 Copyright © 2012, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

Upload: vuongkien

Post on 30-Dec-2016

216 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

ISPOR 17TH ANNUAL INTERNATIONAL MEETING FINANCIAL DISCLOSURE INFORMATION FOR RESEARCH PRESENTATIONS

The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose financial support for their research.The following financial support was declared:

ReferenceCode Financial Support

ReferenceCode Financial Support

CE1 NoneCE2 NoneCE3 National Pharmaceutical Council, Washington, DC, USACE4 NoneCN1 Healthcare and Social Agency, Emilia-Romagna Region, ItalyCN2 Abbott Laboratories, Abbott Park, IL, USACN3 American Cancer Society, Atlanta, GA, USACN4 Bayer HealthCare Pharmaceuticals, Pine Brook, NJ, USACO1 NoneCO2 NoneCO3 Agency for Healthcare Research and Quality, Rockville, MD, USACO4 GlaxoSmithKline Biologicals, Rixensart, BelgiumCV1 NoneCV2 Kantar Health, Princeton, NJ, USACV3 NoneCV4 NoneDR1 NoneDR2 NoneDR3 Canadian Institutes of Health Research, Ottawa, ON, CanadaDR4 National Pharmaceutical Council, Washington, DC, USAHC1 NoneHC2 Sunovion Pharmaceuticals, Inc., Marlborough, MA, USAHC3 NoneHC4 NoneIN1 NoneIN2 Bristol-Myers Squibb Company, Plainsboro, NJ, USAIN3 GlaxoSmithKline Biologicals, Wavre, BelgiumIN4 Pfizer Inc., Collegeville, PA, USAMA1 Eli Lilly & Co., Indianapolis, IN, USAMA2 Janssen Scientific Affairs, LLC, Horsham, PA, USAMA3 Eli Lilly and Company, Indianapolis, IN, USAMA4 Sanofi-Aventis U.S., Bridgewater, NJ, USAME1 NoneME2 NoneME3 National Cancer Institute, Bethesda, MD, USAME4 Paradigm Spine, LLC, New York, NY, USAMO1 NoneMO2 Genentech, Inc., South San Francisco, CA, USAMO3 Agency for Healthcare Research and Quality, Rockville, MD, USAMO4 NonePCN1 NonePCN2 West Virginia University CoHORTS Centre, Morgantown, WV, USAPCN3 American Cancer Society, Atlanta, GA, USAPCN4 American Cancer Society, Atlanta, GA, USAPCN5 NonePCN6 NonePCN7 NonePCN8 NonePCN9 F. Hoffmann-La Roche Pharmaceuticals AG, Basle, SwitzerlandPCN10 Pfizer, São Paulo, BrazilPCN11 Bayer Healthcare, Wayne, NJ, USAPCN12 Bayer Healthcare, Wayne, NJ, USAPCN13 NonePCN14 NonePCN15 Bayer Healthcare, Wayne, NJ, USAPCN16 Bristol-Myers Squibb, Princeton, NJ, USAPCN17 Bayer Healthcare, Wayne, NJ, USAPCN18 NonePCN19 NonePCN20 NonePCN21 NonePCN23 NonePCN24 Productos Roche S.A, Bogotá D.C, ColombiaPCN25 American Cancer Society, Atlanta , GA, USAPCN26 Pliva Croatia Ltd., Zagreb, CroatiaPCN27 Novartis, East Hanover, NJ, USAPCN28 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN29 CPP - Customized Premium Products, S.A. de C.V, Mexico City, MexicoPCN30 NonePCN31 United Medical, São Paulo, BrazilPCN32 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USAPCN33 Eli Lilly and Company, Indianapolis, IN, USAPCN34 NonePCN35 Janssen Scientific Affairs, LLC, Horsham, PA, USA

PCN36 Janssen Scientific Affairs, LLC, Horsham, PA, USAPCN37 F. Hoffmann-La Roche Pharmaceuticals AG, Basle, SwitzerlandPCN38 NonePCN39 Abbott Laboratories, Abbott Park, IL, USAPCN40 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USAPCN41 GlaxoSmithKline, Philadelphia, PA, USAPCN42 NonePCN43 NonePCN44 Eisai, Inc., Woodcliff Lake, NJ, USAPCN45 Roche Polska Sp. z o.o., Warsaw, PolandPCN46 NonePCN47 Bayer Healthcare, Wayne, NJ, USAPCN48 GSK, Rio de Janeiro, BrazilPCN49 Bristol-Myers Squibb, Plainsboro, NJ, USAPCN50 Genzyme, Toronto, ON, CanadaPCN51 Bayer HealthCare Pharmaceuticals, Pine Brook, NJ, USAPCN52 Janssen-Cilag, Sao Paulo, BrazilPCN53 Bayer Healthcare, Wayne, NJ, USAPCN54 Bayer HealthCare Pharmaceuticals, Pine Brook, NJ, USAPCN55 Bayer Healthcare, Wayne, NJ, USAPCN56 NonePCN57 Novartis, Hong Kong, ChinaPCN58 NonePCN59 GSK, Rio de Janeiro, BrazilPCN60 Novartis Oncology Colombia, Bogota D.C, ColombiaPCN61 Pfizer, Mexico City, MexicoPCN62 Pfizer SAS, Bogota, ColombiaPCN63 Universidad Nacional de Colombia, Bogotá, ColombiaPCN64 NonePCN65 Janssen Cilag, Bogota, ColombiaPCN66 Janssen-Cilag AB, Sollentuna, SwedenPCN67 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN68 Glaxo Smith Kline, Bogota, ColombiaPCN69 NonePCN70 GlaxoSmithKline, Mexico City, MexicoPCN71 Pierre-Fabre Farma de MMéexico, S.A. De C.V., MMéexico DF, MexicoPCN72 NonePCN73 Pfizer S.A. de C.V., Ciudad de MMéexico, MexicoPCN74 Novartis, Mexico, MexicoPCN75 NonePCN76 NonePCN77 NonePCN78 NonePCN79 NonePCN80 Phizer, Moscow, RussiaPCN81 Roche Products Ltd., Taipei, TaiwanPCN82 NonePCN83 Celgene Corporation, Summit, NJ, USAPCN84 NonePCN85 NonePCN86 NonePCN87 NonePCN88 Genzyme, Mississauga, ON, CanadaPCN89 NonePCN91 NonePCN92 Celgene Inc., Mississauga, ON, CanadaPCN93 NonePCN94 NonePCN95 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN96 Bristol-Myers Squibb, Wallingford, CT, USAPCN97 Abbott Laboratories, Abbott Park, IL, USAPCN98 National Health and Medical Research Council, Canberra, AustraliaPCN99 Centers for Disease Control and Prevention, Atlanta, GA, USAPCN100 National Science Council, Taipei, TaiwanPCN102 Eli Lilly and Company, Indianapolis, IN, USAPCN103 Celgene Corporation, Summit, NJ, USAPCN104 Amgen, Thousand Oaks, CA, USAPCN105 Bayer HealthCare Pharmaceuticals, Wayne, NJ, USAPCN106 Center for Medical Technology Policy, Baltimore, MD, USAPCN107 Janssen Scientific Services, LLC, Horsham, PA, USAPCN108 Abbott, Abbott Park, IL, USAPCN109 Incyte Corporation, Wilmington, DE, USAPCN110 Boehringer Ingelheim International GmbH, Ingelheim, GermanyPCN111 Celgene Corporation, Summit, NJ, USA

A257V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 2 5 7 – A 2 6 5

Copyright © 2012, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

Page 2: ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

PCN112 Astellas PGD, Leiderdorp, NetherlandsPCN113 NonePCN114 West Virginia University CoHORTS Centre, Morgantown, WV, USAPCN115 Eisai, Inc., Woodcliff Lake, NJ, USAPCN116 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN117 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN118 AHRQ, Bethesda, MD, USAPCN119 Ministry of Health, Kuala Lumpur, MalaysiaPCN120 Harvard Department of Population Medicine (PhD Fellowship), Boston, MA,

USA; IMS Institute for Healthcare Informatics (data provided in-kind),Parsippany, NJ, USA

PCN121 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN122 Amgen, Thousand Oaks, CA, USAPCN123 GlaxoSmithKline, Philadelphia, PA, USAPCN124 Vifor Pharma, Neuilly-sur-Seine, FrancePCN125 NonePCN126 NonePCN127 NonePCN128 WVU CoHORTS Center, Morgantown, WV, USA; Mary Babb Randolph Cancer

Center, Morgantown, WV, USAPCN129 WVU CoHORTS Center, Morgantown, WV, USA; Mary Babb Randolph Cancer

Center, Morgantown, WV, USAPCN130 United Healthcare Pharmacy, Edina, MN, USAPCN131 Amgen, Thoisand Oaks, CA, USAPCN132 NonePCN133 BD, Franklin Lakes, NJ, USAPCN134 NonePCN135 PAREXEL International, Waltham, MA, USAPCN136 NonePCN137 Amgen, Thousand Oaks, CA, USAPCN138 NonePCN139 Janssen Scientific Affairs, LLC, Horsham, PA, USAPCN140 NonePCN141 Merck, Sharpe & Dorne, Co., Whitehouse Station, NJ, USAPCN142 Celgene Corporation, Summit, NJ, USAPCN143 NonePCN144 Amgen, Thousand Oaks, CA, USAPCN145 Bristol-Myers Squibb MMéexico, MexicoPCN146 Bayer HealthCare Pharmaceuticals, Pine Brook, NJ, USAPCN147 NonePCN148 Costello Medical Consulting Ltd., Cambridge, UKPCN149 NonePCN150 NonePCN151 BMS, Lawrenceville, NJ, USAPCN153 NCI, Washington DC, DC, USAPCN154 Cornerstone Research Group, Burlington, ON, CanadaPCN155 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN156 NonePCN157 NonePCN158 Bristol-Myers Squibb, Princeton, NJ, USAPCV1 NonePCV2 Janssen Scientific Affairs, LLC, Titusville, NJ, USAPCV3 Janssen Scientific Affairs, LLC, Raritan, NJ, USAPCV4 Janssen Scientific Affairs, LLC, Raritan, NJ, USAPCV5 NonePCV6 Center for Medicare and Medicaid Services, Baltimore, MD, USAPCV7 Sanofi-Aventis U.S., Bridgewater, NJ, USAPCV8 Janssen Scientific Affairs, LLC, Raritan, NJ, USAPCV9 Merck & Co., Inc., Whitehouse Station, NJ, USAPCV10 AstraZeneca, Paris, FrancePCV11 Bayer Yakuhin, Ltd., Osaka, JapanPCV12 NonePCV13 NonePCV14 Novartis Pharma AG, Basel, SwitzerlandPCV15 NonePCV16 NonePCV17 Daiichi Sankyo, Parsippany, NJ, USAPCV18 NonePCV19 Pfizer, Inc., New York, NY, USAPCV20 Health Insurance Review and Assessment Service, Seoul, South KoreaPCV21 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

Inc., Montgomery, AL, USAPCV22 Bayer Pharma AG, Berlin, GermanyPCV23 NonePCV24 NonePCV25 NonePCV26 NonePCV27 NonePCV28 The Medicines Company, Parsippany, NJ, USAPCV29 Agency for Healthcare Research and Quality, Rockville, MD, USAPCV30 AstraZeneca Pharmaceuticals, Wilmington, DE, USA

PCV31 AstraZeneca Hong Kong, Hong Kong, ChinaPCV32 Bayer Pharma AG, Berlin, GermanyPCV33 NonePCV34 NonePCV35 NonePCV36 Janssen Scientific Affairs, LLC, Titusville, NJ, USAPCV37 NonePCV38 NonePCV39 Novartis, East Hanover, NJ, USAPCV40 Novartis, East Hanover, NJ, USAPCV41 Boehringer Ingelheim, Moscow, RussiaPCV42 Bayer Turk, Istanbul, TurkeyPCV43 Bristol-Myers Squibb, Princeton, NJ, USA; Pfizer, New York, NY, USAPCV44 BMS, Princeton, NJ, USA; Pfizer, New York, NY, USAPCV45 NonePCV46 Haute Autorité de Santé, Saint-Denis-la-Plaine, FrancePCV47 GSK, Rio de Janeiro, BrazilPCV48 BOEHRINGER INGELHEIM, Sao Paulo, BrazilPCV49 NonePCV50 Takeda Pharmaceuticals International, Inc., Deerfield, IL, USAPCV51 Boehringer Ingelheim, Bogota, ColombiaPCV52 Nycomed, Moscow, RussiaPCV53 Boehringer Ingelheim RCV GmbH & Co., KG, Bratislava, Slovak RepublicPCV54 NonePCV55 AstraZeneca, Mexico, MexicoPCV56 Boehringer Ingelheim, Sao Paulo, BrazilPCV57 NonePCV58 Sanofi, Istanbul, TurkeyPCV59 Boehringer Ingelheim, Moscow, RussiaPCV60 Assistance Publique - Hopitaux de Paris, Paris, FrancePCV61 NonePCV62 NonePCV63 National Business Group on Health, Washington, DC, USAPCV64 Novartis, East Hanover, NJ, USAPCV65 Monash University, Melbourne, AustraliaPCV66 Merck and Co., Inc., Whitehouse Station, NJ, USAPCV67 Sanofi-Aventis, Bridgewater, NJ, USA; Bristol-Myers Squib, New York, NY,

USAPCV68 Nestle Health Science, Vevey, SwitzerlandPCV69 Daiichi Sankyo, Munich, GermanyPCV70 NonePCV71 Pfizer, Inc., New York, NY, USAPCV72 NonePCV73 NonePCV74 Express Scrpts, Inc., St. Louis, MO, USAPCV75 NonePCV76 University of Illinois at Chicago (UIC) Center for Clinical and Translational

Science (CCTS), Award Number KL2RR029878 from the National Center forResearch Resources, Chicago, IL, USA

PCV77 NonePCV78 NonePCV79 Janssen Scientific Affairs, LLC, Raritan, NJ, USAPCV80 Smith and Nephew Foundation, London, UKPCV81 Pfizer Pharmaceuticals Korea Ltd., Seoul, South KoreaPCV82 PFSA, Boulogne Billancourt, FrancePCV83 NonePCV84 Allergan, Irvine, CA, USAPCV85 NonePCV86 NonePCV87 GetWellNetwork Inc., Bethesda, MD, USAPCV88 NonePCV89 NonePCV90 Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyPCV91 Aetna Foundation, Hartford, CT, USA; Kaiser Permanente Cares for

Communities Grant, Oakland, CA, USAPCV92 NonePCV93 NonePCV94 NonePCV95 NonePCV96 NonePCV97 Novartis Pharmaceuticals, Basel, SwitzerlandPCV98 Janssen Scientific Affairs, LLC, Raritan, NJ, USA; National Institutes of

Health, Bethesda, MD, USAPCV99 Bristol-Myers Squibb SA, São Paulo, BrazilPCV100 Novartis Pharma AG, Basel, SwitzerlandPCV101 AstraZeneca, Södertälje, SwedenPCV102 Novartis Pharma AG, Basel, SwazilandPCV103 Bristol-Myers Squibb S/A, São Paulo, BrazilPCV104 NonePCV105 AstraZeneca Italia, Milano, ItalyPCV106 Cardinal Health Foundation, Columbus, OH, USA

ReferenceCode Financial Support

ReferenceCode Financial Support

A258 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 2 5 7 – A 2 6 5

Page 3: ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

PCV107 NonePCV108 Pfizer Ltd, Walton Oaks, UKPCV109 NonePCV110 NonePCV111 NonePCV112 Agency for Health Technology Assessment, Warsaw, PolandPCV113 RWJF Center for Health Policy, Albuquerque, NM, USAPCV114 NonePCV115 Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USAPCV116 NonePCV117 Janssen Pharmaceutical Companies of Johnson & Johnson, Raritan, NJ, USAPCV118 Eli Lilly & Co., Indianapolis, IN, USAPCV119 NonePCV121 Pfizer Ltd., Tadworth, Surrey, UKPCV122 NonePCV123 NIH, Bethesda, MD, USAPCV124 NonePDB1 Bristol-Myers Squibb, Princeton, NJ, USAPDB2 NonePDB3 Boehringer Ingelheim, Toronto, ON, CanadaPDB4 Merck, Hang Zhou, ChinaPDB5 NonePDB6 NonePDB7 NonePDB8 Bristol-Myers Squibb, Princeton, NJ, USA; AstraZeneca, Wilmington, DE, USAPDB9 NonePDB10 NonePDB11 Sanofi-Aventis U.S., Bridgewater, NJ, USAPDB12 Department of Veterans Affairs, Veterans Health Administration, Office of

Research and Development, Clinical Sciences Research and Development,Cooperative Studies Program, Washington, DC, USA; American Society ofHealth-System Pharmacists Foundation, Bethesda, MD, USA

PDB13 Pfizer SAS, Bogota, ColombiaPDB14 NonePDB15 Merck & Co., Inc., Whitehouse Station, NJ, USAPDB16 Novo Nordisk, Princeton, NJ, USAPDB17 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPDB18 NonePDB19 NonePDB20 NPS Pharmaceuticals, Bedminster, NJ, USAPDB21 Kantar Health, Princeton, NJ, USAPDB22 Novo Nordisk Inc., Princeton, NJ, USAPDB23 NonePDB24 NonePDB25 NonePDB26 National Center on Minority Health and Health Disparities, Washington, DC,

USAPDB28 NonePDB29 Novo Nordisk Inc., Princeton, NJ, USAPDB30 Endo Pharmaceutical, Chadds Ford, PA, USAPDB31 Tethys Bioscience, Inc., Emeryville, CA, USAPDB32 Otsuka America Pharmaceutical, Rockville, MD, USAPDB33 NonePDB34 Sanofi-Aventis U.S., Bridgewater, NJ, USAPDB35 Otsuka America Pharmaceutical, Inc., Princeton, NJ, USAPDB36 Bristol-Myers Squibb Company, Plainsboro, NJ, USA; AstraZeneca LP,

Wilmington, DE, USAPDB37 Novo Nordisk Inc., Princeton, NJ, USAPDB38 NonePDB39 Novo Nordisk Inc., Princeton, NJ, USAPDB40 NonePDB41 National Center on Minority Health and Health Disparities, Washington, DC,

USAPDB42 Boehringer-Ingelheim, Burlington, ON, CanadaPDB43 Sanofi, Paris, FL, FrancePDB44 NonePDB45 Novo Nordisk A/S, Søborg, DenmarkPDB46 Novo Nordisk A/S, Søborg, DenmarkPDB47 Novo Nordisk A/S, Søborg, DenmarkPDB48 Novo Nordisk A/S, Søborg, DenmarkPDB49 NonePDB50 Novo Nordisk Inc., Princeton, NJ, USAPDB51 Amylin Pharmaceuticals, San Diego, CA, USA; Eli Lilly and Company,

Indianapolis, IN, USA; IMS Consulting Group, Alexandria, VA, USAPDB52 Health Technology Assessment, London, UKPDB53 Bristol-Myers Squibb, Princeton, NJ, USA; AstraZeneca, London, UKPDB54 NonePDB55 Eli Lilly, Indianapolis, IN, USAPDB56 Novo Nordisk, Princeton, NJ, USAPDB57 NonePDB58 None

PDB59 NonePDB60 NonePDB61 Novo Nordisk, Princeton, NJ, USAPDB62 NIHR Grant, UKPDB63 NonePDB64 NonePDB65 Novo Nordisk, Princeton, NJ, USAPDB66 NonePDB67 National Business Group on Health, Washington, DC, USAPDB68 NonePDB69 Novo Nordisk, Soborg, DenmarkPDB70 NonePDB71 NonePDB72 Bristol-Meyers Squibb, Wallingford, CT, USAPDB73 NonePDB74 NonePDB75 NonePDB76 National University of Singapore, Singapore, SingaporePDB77 Pfizer Pharmaceuticals Korea Ltd., Seoul, South KoreaPDB78 Houston VA HSR&D Center of Excellence (HFP 90-020), Houston, TX, USAPDB79 NonePDB80 Novo Nordisk, Princeton, NJ, USAPDB81 NonePDB82 New Life Laboratories Private Limited, Bhopal, IndiaPDB83 NonePDB84 National Healthcare Group, Singapore, SingaporePDB85 NonePDB86 NonePDB87 NonePDB88 NonePDB89 NonePDB90 NonePDB91 NonePDB92 NonePDB93 NonePDB94 NonePDB95 Arkansas Center for Translational Research Institute , Little Rock , AR, USAPDB96 NonePDB97 Eli Lilly and Company, Indianapolis, IN, USAPDB98 Novo Nordisk, Copenhagen, DenmarkPDB99 NonePDB100 AstraZeneca, Wilmington, DE, USAPDB101 Bristol - Meyers Squibb, São Paulo, BrazilPDB102 CHARTA, Milan, ItalyPDB103 NonePDB104 NonePDB105 Medco Research Institute, LLC. Medco Health Solutions, Inc., Bethesda, MD,

USA; Sanofi US, Bridgewater, NJ, USAPDB106 NonePDB107 Eli Lilly and Company, Indianapolis, IN, USAPDB109 NonePDB110 National Health and Medical Research Council, Canberra, Australia; NIH,

Boston, MA, USAPDB111 National Institute for Health Research, London, UKPGI1 Pacira Pharmaceuticals, Parcippany, NJ, USAPGI2 National Science Council, Taipei, TaiwanPGI3 Shire Development, Wayne, PA, USAPGI5 NonePGI6 NonePGI7 Takeda Pharmaceuticals International, Inc., Deerfield, IL, USAPGI8 Pfizer Inc., New York, NY, USAPGI9 Takeda Pharmaceuticals International, Inc., Deerfield, IL, USAPGI10 Merck, Whitehouse Station, NJ, USAPGI11 NonePGI12 Abbott Canada, St-Laurent, QC, CanadaPGI13 Ferring Pharmaceuticals, São Paulo, BrazilPGI14 GlaxoSmithkline, Philadelphia, PA, USAPGI15 Forest Research Institute, Jersey City, NJ, USA; Ironwood Pharmaceuticals,

Cambridge, MA, USAPGI16 Shire, Wayne, PA, USAPGI17 Epac, Milan, ItalyPGI18 Epac, Milan, ItalyPGI19 Epac, Milan, ItalyPGI20 Shire Development, LLC, Wayne, PA, USAPGI21 NonePGI22 Astra Zeneca, Mexico City, MexicoPGI23 NonePGI24 Merck Sharp and Dohme, São Paulo, BrazilPGI25 Merck Sharp and Dohme, São Paulo, BrazilPGI26 Shire Development LLC, Wayne, PA, USAPGI27 None

ReferenceCode Financial Support

ReferenceCode Financial Support

A259V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 2 5 7 – A 2 6 5

Page 4: ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

PGI28 Takeda Pharmaceuticals International, Inc., Deerfield, IL, USAPGI29 Shire Development, Inc., Wayne, PA, USAPGI30 NonePGI31 Fondazione FADE, Milano, ItalyPHP1 CMTP, Baltimore, MD, USAPHP2 NonePHP3 Merck & Co, Inc., Whitehouse Station, NJ, USAPHP4 NonePHP5 AHRQ, Rockville, MD, USAPHP6 The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva,

SwitzerlandPHP7 NonePHP8 NonePHP9 European Commission FP7 Programme, Brussels, BelgiumPHP10 NonePHP11 Brazilian Health Surveillance Agency (Anvisa), Brasília, BrazilPHP12 NonePHP13 PhRMA Foundation, Washington, DC, USA; American Foundation for

Pharmaceutical Education, Rockville, MD, USAPHP14 NonePHP15 NonePHP16 Novartis Pharma AG, Basel, SwitzerlandPHP17 NonePHP18 NonePHP19 Janssen Scientific Affairs, LLC, Horsham, PA, USAPHP20 Pfizer, Inc., New York, NY, USAPHP21 NonePHP22 Eli Lilly and Company, Indianapolis, IN, USAPHP23 NonePHP24 NonePHP25 Walgreen Co, Deerfield, IL, USAPHP26 WVU CoHORTS Center, Morgantown, WV, USAPHP27 NonePHP28 NonePHP29 NonePHP30 NonePHP31 NonePHP32 NonePHP34 NonePHP35 New Taipei City Hospital, New Taipei, TaiwanPHP36 Abbott Italy, Rome, ItalyPHP37 NonePHP38 NonePHP39 NonePHP40 National Institute on Aging, Bethesda, MD, USA; RAND Health Bing Center

for Health Economics, Santa Monica, CA, USAPHP41 Joint Procurement Department, Amman, JordanPHP42 PhRMA, Washington, DC, USAPHP43 NonePHP44 NonePHP45 Ministry of Health, Buenos Aires, ArgentinaPHP46 F. Hoffmann - La Roche AG, Basel, SwitzerlandPHP47 Qatar University, Doha, QatarPHP49 NonePHP50 Brazilian Health Surveillance Agency, Brasilia, BrazilPHP51 General Electric Healthcare, Bucks, UKPHP52 NonePHP53 Thomson Reuters, Cambridge, MA, USAPHP54 NonePHP55 NonePHP56 NonePHP57 NonePHP58 Walgreen Co, Deerfield, IL, USAPHP59 Ministry of Health, Labour and Welfare, Tokyo, JapanPHP60 NonePHP61 NonePHP62 NonePHP63 Department of Health, Taipei, Taiwan; National Science Council, Taipei,

TaiwanPHP64 Agency for Healthcare Research and Quality, Rockville, MD, USAPHP65 NonePHP66 Costello Medical Consulting, Cambridge, UKPHP67 NonePHP68 NonePHP69 NonePHP70 HHS/ONC/OEM, Washington, DC, USAPHP71 NonePHP72 NonePHP73 NonePHP74 Agency for Health Technology Assessment, Warsaw, PolandPHP75 None

PHP76 ASHP Foundation, Bethesda, MD, USAPHP77 ASHP Foundation, Bethesda, MD, USAPHP78 Agency for Healthcare Research and Quality, Rockville, MD, USAPHP79 Purdue University, Regenstrief Center for Health Care Engineering, West

Lafayette, IN, USAPHP81 NonePHP82 NonePHP83 NonePHP84 Health Resources and Services Administration Grant D34HP6042,

Washington, DC, USAPHP85 Agency for Healthcare Research and Quality, Silver Spring, MD, USAPHP86 NonePHP87 United States Pharmacopeia, Rockville, MD, USAPHP88 NonePHP89 NonePHP90 Office of Research, Development and Information, Centers for Medicare and

Medicaid Services (CMS), Washington, DC, USAPHP91 Agency for Healthcare Research and Quality, Rockville, MD, USAPHP92 GE Healthcare, Wauwatosa, WI, USAPHP93 Kentucky Cabinet for Health and Family Services, Frankfort, KY, USAPHP94 HERON Evidence Development, Somerville, NJ, USAPHP95 NonePHP96 General Electric Healthcare, Chalfont St. Giles, UKPHP97 IHS Consulting, Washington, DC, USAPHP98 Heron Evidence Development, LLC, Somerville, NJ, USAPHP99 NonePHP100 GlaxoSmithKline, London, UKPHP101 NonePHP102 GSK, Wavre, BelgiumPHP103 NonePHP104 NonePHP105 NonePHP106 NonePHP107 NonePHP108 PAREXEL International, Waltham, MA, USAPHP109 NonePHP110 NonePHP111 NonePHP112 NonePIH1 Agency for Healthcare Research and Quality, Rockville, MD, USAPIH2 Eli Lilly and Company, Indianapolis, IN, USAPIH3 Bayer Pharma AG, Berlin, GermanyPIH4 NonePIH5 GSK, Rio de Janeiro, BrazilPIH6 Agency for Healthcare Research and Quality, Rockville, MD, USAPIH7 Agency for Healthcare Research and Quality, Rockville, MD, USAPIH8 Abbott Laboratories, Abbott Park, IL, USAPIH9 NonePIH10 NonePIH11 Novartis Pharmaceutical Corporation, East Hanover, NJ, USAPIH12 GlaxoSmithKline, Mississauga, ON, CanadaPIH13 Eisai, Inc., Woodcliff Lake, NJ, USAPIH14 Pfizer, New York , NY, USAPIH15 NonePIH16 GlaxoSmithKline, Mississauga, ON, CanadaPIH17 Pfizer CIA LTDA, Quito, EcuadorPIH18 Ministry of Health, Brasilia, Brazil; National Council of Technological and

Scientific Development (CNPq), Brasilia, Brazil; National Institute of Scienceand Technology for Health Technology Assessment (IATS), Porto Alegre,Brazil

PIH19 NonePIH20 Laboratorio Farmacéutico Bayer Schering Pharma Colombia, Bogotá D.C.,

ColombiaPIH21 NonePIH22 The Hospital for Sick Children, Toronto, ON, CanadaPIH23 Pfizer Inc., Collegeville, PA, USAPIH24 Centers for Medicare & Medicaid Services, Baltimore, MD, USA; National

Institute on Aging, Bethesda, MD, USA; MacArthur Foundation, Chicago, IL,USA

PIH25 Pfizer Inc., Collegeville, PA, USAPIH26 NonePIH27 NonePIH28 Heron Evidence Development, Somerville, NJ, USAPIH29 CVS CAREMARK, Woonsocket, RI, USAPIH30 NonePIH31 Pfizer Inc., New York, NY, USAPIH32 Kantar Health, New York, NY, USAPIH33 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPIH34 Virginia Commonwealth University, Richmond, VA, USAPIH35 CVS CAREMARK, Woonsocket, RI, USA

ReferenceCode Financial Support

ReferenceCode Financial Support

A260 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 2 5 7 – A 2 6 5

Page 5: ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

PIH36 The Commonwealth Found, New York, NY, USA; International Academy ofLife Science, Hannover, Germany

PIH37 Merck & Co., Inc., North Wales, PA, USAPIH38 Merck & Co, Inc., North Wales, PA, USAPIH39 EuroQol Group, Rotterdam, NetherlandsPIH40 NonePIH41 NonePIH42 NonePIH43 NonePIH44 Agency for Healthcare Research and Quality, Rockville, MD, USAPIH45 NonePIH46 NonePIH47 BOIRON, Sainte-Foy-lès-Lyon, FrancePIH48 Endo, Chadds Ford, PA, USAPIH49 Novartis, East Hanover, NJ, USAPIH50 Eli Lilly and Company, Indianapolis, IN, USAPIH51 NonePIH52 NonePIH53 Novartis, East Hanover, NJ, USAPIH54 Novartis Pharmaceuticals, East Hanover, NJ, USAPIH55 NonePIH56 Plastic Surgery Foundation, Arlington Heights, IL, USAPIH57 NonePIH58 NonePIH59 NonePIH60 NonePIH61 Pfizer Pharmaceuticals, Inc., New York, NY, USAPIH62 NonePIH63 NonePIH64 Boiron, Lyon, FrancePIH65 Baxter Healthcare Corporation, Westlake Village, CA, USAPIH66 NonePIH67 Purdue University, Regenstrief Center for HealthCare Engineering, West

Lafayette, IN, USAPIH68 CDCH Central University of Venezuela, Caracas, VenezuelaPIH69 Pfizer Pharmaceutical Korea Limited, Seoul, South KoreaPIH70 ADB, Ulaanbaatar, MongoliaPIH71 NonePIH72 NonePIH73 Departamento Administrativo de Ciencia, Tecnología e Innovaciyn -

Colciencias, Bogotá, Colombia; Universidad Nacional de Colombia, Bogotá,Colombia

PIH74 Universidad Nacional de Colombia, Bogotá, ColombiaPIH75 Departamento Administrativo de Ciencia, Tecnología e Innovación -

Colciencias, Bogota, Colombia; Universidad Nacional de Colombia, Bogota,Colombia

PIH76 Bayer Yakuhin, Tokyo, JapanPIH77 Eisai, Inc., Woodcliff Lake, NJ, USAPIH78 NonePIH79 Eli Lilly and Company, Indianapolis, IN, USAPIH80 NonePIH81 NonePIH82 Pfizer, Inc., New York, NY, USAPIH83 The Hospital for Sick Children, Toronto, ON, CanadaPIH84 PPD, Wilmington, NC, USAPIH85 TOHO University, Tokyo, JapanPIN1 NonePIN2 NonePIN3 Cubist Pharmaceuticals, Lexington, MA, USAPIN4 Stendhal, Mexico City, MexicoPIN5 NonePIN6 NonePIN7 NonePIN8 Forest Research Institute, Inc., Jersey City, NJ, USAPIN9 Novartis International AG, Basel, SwitzerlandPIN10 Forest Research Institute, Inc., Jersey City, NJ, USAPIN11 Pfizer Inc., Groton, CT, USAPIN12 NonePIN13 Optimer Pharmaceuticals, Inc., San Diego, CA, USAPIN14 Astellas Pharma US, Inc., Deerfield, IL, USAPIN15 Pfizer, Inc., Collegeville, PA, USAPIN16 NIPER, S.A.S. NAGAR, IndiaPIN17 Pfizer, New York, NY, USAPIN18 Pfizer S.A. de C.V., Ciudad de MMéexico, MexicoPIN19 Pan American Health Organization, Washington, DC, DC, USAPIN20 Pan American Health Organization, Washington, DC, DC, USAPIN21 World Health Organization, Geneva, SwitzerlandPIN22 The Medicines Company, Parsippany, NJ, USAPIN23 Biotest, Budapest, HungaryPIN24 Centers for Disease Control and Prevention, Atlanta, GA, USAPIN25 Bristol-Myers Squibb, Plainsboro, NJ, USA

PIN26 Bayer HealthCare Pharma, Moscow, RussiaPIN27 Janssen, High Wycombe, UKPIN28 Pfizer SAS, Bogota, ColombiaPIN29 NonePIN30 CIHR, Ottawa, ON, CanadaPIN31 Pfizer SAS, Bogota, ColombiaPIN32 Pfizer S.A. de C.V., Ciudad de MMéexico, MexicoPIN33 Pfizer Canada Inc., Montreal, QC, CanadaPIN34 Pfizer Inc., Quito, EcuadorPIN35 NonePIN36 Pfizer SAS, Bogota, ColombiaPIN37 Bristol-Myers Squibb SARL, Rueil Malmaison, FrancePIN38 Pfizer Korea, Seoul, South KoreaPIN39 Pfizer SAS, Bogota, ColombiaPIN40 NonePIN41 NonePIN42 Janssen, High Wycombe, UKPIN43 Laboratorios Stendhal, Mexico City, MexicoPIN44 Abbott S.r.l., Campoverde di Aprilia (LT), ItalyPIN45 Merck & Co, Inc., Whitehouse Station, NJ, USAPIN46 NonePIN47 Bristol-Myers Squibb, Princeton, NJ, USAPIN48 NonePIN48 NonePIN49 Sanofi Pasteur MSD, Lyon, FrancePIN50 Pfizer Inc., New York, NY, USAPIN51 NonePIN53 Double Helix Development, New York, NY, USAPIN54 NonePIN55 Pfizer, New York, NY, USAPIN56 NonePIN57 Spanish National I�D Program, Madrid, SpainPIN58 NonePIN59 Pfizer S.A. de C.V., Ciudad de MMéexico, MexicoPIN60 Pfizer, New York, NY, USAPIN61 Merck and Company, Whitehouse Station, NJ, USAPIN62 Mississippi Division of Medicaid, Jackson, MS, USAPIN63 Pfizer Colombia, Bogota, ColombiaPIN64 ViiV/Pfizer, New York, NY, USAPIN65 HTA Consulting, Cracow, PolandPIN66 Pfizer Inc., New York, NY, USAPIN67 Bristol-Myers Squibb, Plainsboro, NJ, USAPMD1 NonePMD2 Nork Marash Medical Center, Yerevan, ArmeniaPMD3 Physiotherapy Foundation of Canada, Ottawa, ON, CanadaPMD4 ENSP, Rio de Janeiro, BrazilPMD5 Bayer, Wayne, NJ, USAPMD6 NonePMD7 NonePMD8 Ontario Ministry of Health and Long-term Care, Toronto, ON, CanadaPMD9 NonePMD10 National Science Council, Taipei, Taiwan; Department of Health, Taipei,

TaiwanPMD11 Johnson & Johnson Medical Products Canada, Markham, ON, CanadaPMD12 St Jude Medical, St Paul, MN, USAPMD13 GUERBET SA, Villepinte, FrancePMD14 Biosense Webster, Inc., Diamond Bar, CA, USAPMD15 Biosense Webster, Inc., Diamond Bar, CA, USAPMD16 Biosense Webster, Inc., Diamond Bar, CA, USAPMD17 Johnson & Johnson Medical, Mexico City, MexicoPMD18 Baxter, Los Angeles, CA, USAPMD19 Medtronic, Inc., Northridge, CA, USAPMD20 DePuy Mitek Inc., Raynham, MA, USAPMD21 NonePMD22 Medtronic Spinal and Biologics, Memphis, TN, USAPMD23 Biomet Spine & Bone Healing Technologies, Parsippany, NJ, USAPMD24 NonePMD25 NonePMD26 NonePMD27 Medtronic, Brampton, ON, CanadaPMD28 NonePMD29 NonePMD30 NonePMD31 QIAGEN.K.K, Tokyo, JapanPMD32 NonePMD33 Thermo Fisher Scientific, Uppsala, SwedenPMD34 Kinetic Concepts Inc., San Antonio, TX, USAPMD35 NonePMD36 Johnson & Johnson Medical Companies, Markham, ON, CanadaPMD37 National Evidence-based Collaborating Agency (NECA), Seoul, South KoreaPMD38 American Sleep Medicine Foundation, Darien, IL, USA

ReferenceCode Financial Support

ReferenceCode Financial Support

A261V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 2 5 7 – A 2 6 5

Page 6: ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

PMD39 Medtronic, København , DenmarkPMD40 NIHR HTA, UKPMD41 Medtronic Diabetes, Northridge, CA, USAPMD42 Paradigm, New York City, NY, USAPMD43 Merck Serono Ltd, London, UKPMD44 DePuy Orthopaedics, Inc, Warsaw, IN, USAPMD45 NonePMD46 NonePMD48 Eucomed, Brussels, BelgiumPMD49 Johnson & Johnson, Buckinghamshire, UKPMD50 double helix consulting, London, UKPMD51 GE Healthcare, Waukesha, WI, USAPMD52 IHS Consulting, Washington, DC, USAPMD53 BD, Franklin Lakes, NJ, USAPMD54 Ameritox Inc., Baltimore, MD, USAPMD55 Baxter Healthcare Corporation, McGaw Park, IL, USAPMD56 Anolinx LLC, Salt Lake City, UT, USA; Genentech Inc., South San Francisco,

CA, USAPMD57 Medtronic Ardian LLC, Mountainview, CA, USAPMD58 NonePMD59 NonePMD60 NonePMD61 Forest Research Institute, Inc., Jersey City, NJ, USAPMD62 CytoPherx, Ann Arbor, MI, USAPMH1 NonePMH2 NonePMH3 NonePMH4 NonePMH5 Bristol-Myers Squibb, New York, NY, USAPMH6 Janssen Scientific Affairs, LLC, Titusville, NJ, USAPMH7 Janssen Scientific Affairs, LLC, Titusville, NJ, USAPMH8 NonePMH9 NonePMH10 NonePMH11 NonePMH12 NonePMH13 AstraZeneca Pharmaceuticals LP, Wilmington, DE, USAPMH14 NonePMH15 NonePMH16 NonePMH17 NonePMH18 Janssen Scientific Affairs, LLC, Titusville, NJ, USAPMH19 Eli Lilly and Company, Indianapolis, IN, USAPMH20 AstraZeneca, Madrid, SpainPMH21 NonePMH22 Faculty of Medicine, Sebelas Maret University (DIPA-BLU Grant 2010), Solo,

IndonesiaPMH23 Pfizer, Inc., New York, NY, USAPMH24 Pfizer, Inc., New York, NY, USAPMH25 AstraZeneca, Basiglio, ItalyPMH26 Sunovion Pharmaceuticals, Marlborough, MA, USAPMH27 Canadian Institutes of Health Research, Ottawa, ON, CanadaPMH28 NonePMH29 NonePMH30 AstraZeneca, Södertälje, SwedenPMH31 Janssen Cilag, Sao Paulo, BrazilPMH32 NonePMH33 Servier, Athens, GreecePMH34 Sunovion Pharmaceuticals Inc., Marlborough, MA, USAPMH35 Servier Ýlaç A.P., Istanbul, TurkeyPMH36 Ministry of Health and Welfare, Seoul, South KoreaPMH37 Lundbeck Canada Inc., Montreal, QC, CanadaPMH38 Lundbeck Canada, Montreal, QC, CanadaPMH39 National Business Group on Health, Washington, DC, USAPMH40 NonePMH41 Pfizer, Inc., New York, NY, USAPMH42 Janssen Scientific Affairs, LLC, Titusville, NJ, USAPMH43 Shire Development, LLC, Wayne, PA, USAPMH44 U.S. National Institutes of Mental Health, Bethesda, MD, USAPMH45 Lundbeck, Copenhagen, DenmarkPMH46 Kantar Health, Princeton, NJ, USAPMH47 NonePMH48 NonePMH49 NonePMH50 Janssen Scientific Affairs, LLC, Titusville, NJ, USAPMH51 Janssen Scientific Affairs, LLC, Titusville, NJ, USAPMH52 Forest Laboratories, Inc., New York, NY, USAPMH53 PAREXEL International, Waltham, MA, USAPMH54 Novartis, East Hanover, NJ, USAPMH55 NonePMH56 AstraZeneca, Madrid, Spain

PMH57 Kantar Health, Princeton, NJ, USAPMH58 Abbott Laboratories, Abbott Park, IL, USAPMH59 Pfizer Pharmaceuticals, Inc., New York, NY, USAPMH60 NonePMH61 Shire Development LLC, Wayne, PA, USAPMH62 NonePMH64 NonePMH65 Shire Pharmaceuticals LLC, Wayne, PA, USAPMH66 Lundbeck, Issy les Moulineaux, FrancePMH67 NonePMH68 Eli Lilly & Co, Indianapolis, IN, USAPMH69 NonePMH70 Eli Lilly & Co., Indianapolis, IN, USAPMH71 NonePMH72 NonePMH73 NonePMH74 NonePMH75 Purdue Pharma, LP, Stamford, CT, USAPMH76 NonePMH77 NonePMH78 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPMH79 Bristol-Myers Squibb, Plainsboro, NJ, USA; Otsuka Pharmaceutical

Development & Commericalization, Princeton, NJ, USAPMH80 NonePMH81 NonePMH82 NonePMH83 Eli Lilly and Co., Indianapolis, IN, USAPMH84 Janssen Scientific Affairs, LLC, Titusville, NJ, USAPMH85 NonePMH86 Sunovion Pharmaceuticals Inc., Marlborough, MA, USAPMH87 NonePMH88 NonePMS1 Eli Lilly & Co, Indianapolis, IN, USAPMS2 Eli Lilly and Company, Indianapolis, IN, USAPMS3 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPMS4 NonePMS5 NonePMS6 NonePMS7 NonePMS8 CIHR / Canadian Arthritis Society Award, Ottawa, ON, Canada; Alberta

Heritage Foundation for Medical Research, Edmonton, AB, CanadaPMS9 Sanofi, Bridgewater, NJ, USAPMS10 PFSA, Boulogne Billancourt, FrancePMS11 PFSA, Boulogne Billancourt, FrancePMS12 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS13 Eli Lilly and Company, Indianapolis, IN, USAPMS14 Eli Lilly and Company, Indianapolis, IN, USAPMS15 NonePMS16 Amgen, Inc., Thousand Oaks, CA, USAPMS17 Janssen Cilag, Sao Paulo, BrazilPMS18 Amgen, Inc., Thousand Oaks, CA, USAPMS19 Pfizer, Collegeville, PA, USAPMS20 Janssen Cilag, Sao Paulo, BrazilPMS21 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS22 Pfizer China, Beijing, ChinaPMS23 Amgen, Inc., Thousand Oaks, CA, USAPMS24 NonePMS25 Pfizer S.A. de C.V., Ciudad de MMéexico, MexicoPMS26 Amgen, Thousand Oaks, CA, USAPMS27 NonePMS28 NonePMS29 Auxilium, Malvern, PA, USAPMS30 NonePMS31 NonePMS32 Pfizer Pharmaceuticals, Inc., New York, NY, USAPMS33 Johnson & Johnson Medical Brasil, São Paulo, BrazilPMS35 Savient Pharmaceuticals, East Brunswick, NJ, USAPMS36 NonePMS37 Pfizer Pharmaceuticals, Istanbul, TurkeyPMS38 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS39 NonePMS40 NonePMS41 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS42 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS43 Kantar Health, New York, NY, USAPMS44 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPMS45 NonePMS46 Genentech Inc., San Francisco, CA, USAPMS47 NonePMS48 Johnson & Johnson, Spring House, PA, USAPMS49 Johnson & Johnson, Spring House, PA, USA

ReferenceCode Financial Support

ReferenceCode Financial Support

A262 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 2 5 7 – A 2 6 5

Page 7: ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

PMS50 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS51 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS52 Janssen Research & Development, LLC, Spring House, PA, USAPMS53 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS54 NonePMS55 NonePMS56 NonePMS57 Roessingh Research & Development, Enschede, NetherlandsPMS58 Pfizer Pharmaceuticals, Inc., New York, NY, USAPMS59 Pfizer Pharmaceuticals, Inc., New York, NY, USAPMS60 Johnson & Johnson, Beijing, ChinaPMS62 NonePMS63 Johnson & Johnson, Beijing, ChinaPMS64 Japan Association of Health Service, Tokyo, JapanPMS65 Productos Roche S. A., Bogotá D.C, ColombiaPMS66 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS67 Pfizer, New York, NY, USAPMS68 Eli Lilly & Company, Indianapolis, IN, USAPMS69 Amgen, Inc., Thousand Oaks, CA, USAPMS70 Amgen Inc., Thousand Oaks, CA, USA; Immunex Corp., Thousand Oaks, CA,

USA; Wyeth/Pfizer, New York, NY, USAPMS71 The Pfizer Health Research Foundation, Tokyo, JapanPMS72 Crescendo Bioscience, South San Francisco, CA, USAPMS73 AHRQ, Rockville, MD, USAPMS74 AHRQ, Rockville, MD, USAPMS75 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS76 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS77 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS78 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS79 Janssen Scientific Affairs, LLC, Horsham, PA, USAPMS80 IHS Consulting, Washington, DC, USAPMS81 Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USAPMS82 Eli Lilly and Company, Inc., Indianapolis, IN, USAPMS83 NonePMS84 NonePMS85 Pfizer, Walton Oaks, UKPMS86 NonePMS87 PFSA, Boulogne Billancourt, FrancePMS88 Pfizer, Paris, FrancePMS89 CIHR / Canadian Arthritis Society Award , Ottawa, ON, Canada; Alberta

Innovates Health Solutions, Edmonton, AB, CanadaPMS90 NonePMS91 Pfizer, Inc., New London, CT, USAPMS92 NonePMS93 Eli Lilly & Company, Indianapolis, IN, USAPMS94 NonePND1 Biogen Idec, Weston, MA, USAPND2 UCB Pharma, Brussels, BelgiumPND3 BiogenIdec, Weston, MA, USAPND4 National Science Council, Taipei, Taiwan; China Medical University,

Taichung, TaiwanPND5 Novartis, Bogotá, ColombiaPND6 Lundbeck US, Deerfield, IL, USAPND7 Depomed, Inc., Menlo Park, CA, USAPND8 Biogen Idec, Weston, MA, USAPND9 CHDI Foundation, Princeton, NJ, USAPND10 EMD Serono, Inc., Rockland, MA, USAPND11 Allergan, Inc., Irvine, CA, USAPND12 Tarang, Mashhad, IranPND13 Lundbeck US, Deerfield, IL, USAPND14 United BioSource Corporation, Lexington, MA, USAPND15 Eisai Inc., Woodcliff Lake, NJ, USAPND16 Pfizer Pharmaceuticals, Inc., New York, NY, USAPND17 Teva Neurosciences, Kansas City, MO, USAPND18 Novartis Pharmaceutical, Mexico City, MexicoPND19 UCB - Biopass, Bogota, ColombiaPND20 TEVA Pharmaceuticals Mexico, Mexico City, MexicoPND21 Lundbeck US, Deerfield, IL, USAPND22 Nycomed: a Takeda ompany, Moscow, RussiaPND23 Biogen Idec, Weston, MA, USAPND24 Eisai, Woodcliff, NJ, USAPND25 NonePND26 Teva Neuroscience, Kansas City, MO, USAPND27 Teva Neuroscience, Kanasa City, MO, USAPND28 Acorda Therapeutics, Inc., Hawthorne, NY, USAPND29 Novartis Pharmaceutical Corporation, East Hanover, NJ, USAPND30 Allergan, LLC, Irvine, CA, CA, USAPND31 Teva Pharmaceutical, Kansas City, MO, USAPND32 Biogen Idec, Weston, MA, USAPND33 NonePND34 Allergan, Inc., Irvine, CA, USA

PND35 GlaxoSmithKline, Research Triangle Park, NC, USAPND36 PhRMA, Washington, DC, USAPND37 UCB Pharma, Brussels, BelgiumPND38 Acorda Therapeutics, Inc., Hawthorne, NY, USAPND39 NonePND40 NonePND41 Medical Research Council, London, UK; Parkinson’s UK, London, UK; UK

Department of Health, London, UKPND42 Pfizer Pharmaceuticals, Inc., New York, NY, USAPND43 Teva Neuroscience, Kansas City, MO, USAPND44 Teva Pharmaceutical, Kansas City, MO, USAPND45 Acorda Therapeutics, Inc., Hawthorne, NY, USAPND46 Genentech, Inc., South San Francisco, CA, USAPND47 MAP Pharmaceuticals, Inc., Mountain View, CA, USAPND48 Novartis Pharmaceutical Corporation, East Hanover, NJ, USAPND49 Teva Pharmaceuticals, Kansas City, MO, USAPND50 Teva Pharmaceuticals, Kansas City, MO, USAPND51 Teva Pharmaceuticals, Kansas City, MO, USAPND52 NonePND53 GlaxoSmithKline, Rio de Janeiro, BrazilPND54 Teva Pharmaceutical, Kansas City, MO, USAPND55 NonePND56 PriceSpective LLC, El Segundo, CA, USAPND57 NonePND58 Quintiles, Hoofddorp, NetherlandsPND59 Teva Pharmaceutical, Kansas City, MO, USAPND60 Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USAPRM1 Health Resources and Services Administration Grant D34HP6042,

Washington, DC, USAPRM2 NonePRM3 Eli Lilly and Company, Indianapolis, IN, USAPRM4 NonePRM5 United Biosource Corporation, Lexington, MA, USAPRM6 Mississippi Division of Medicaid, Jackson, MS, USAPRM7 NonePRM8 NonePRM9 NonePRM10 NonePRM11 NonePRM12 ProVac Initiative. PAHO, Washington, DC, USAPRM13 NonePRM14 NonePRM15 ProVac Initiative. PAHO, Washington, DC, USAPRM16 NonePRM18 ProVac Initiative. PAHO, Washington, DC, USAPRM19 NonePRM20 NonePRM21 NonePRM22 Janssen Scientific Affairs, LLC, Horsham, PA, USAPRM23 NonePRM25 NonePRM26 Quintiles, Hoofddorp, NetherlandsPRM27 NonePRM28 NonePRM29 NonePRM30 NonePRM31 NonePRM32 NonePRM33 NonePRM34 Savient Pharmaceuticals, East Brunswick, NJ, USAPRM35 PharmIdeas Research and Consulting, Oakville, ON, CanadaPRM36 Universidad Nacional de Colombia, Bogota DC, ColombiaPRM37 RTI-Health Solutions, Sheffield, UKPRM38 PatientsLikeMe Inc., Cambridge, MA, USA; Novartis Pharmaceuticals

Corporation, East Hanover, NJ, USAPRM39 PharmIdeas Research and Consulting, Oakville, ON, CanadaPRM40 NonePRM41 NonePRM42 NonePRM43 NonePRM44 DaVita Clinical Research, Minneapolis, MN, USAPRM45 NonePRM46 NonePRM47 NonePRM48 Thomson Reuters, Washington, DC, USAPRM49 NonePRM50 NonePRM51 NonePRM52 NonePRM53 PPD, RTP, NC, USAPRM54 None

ReferenceCode Financial Support

ReferenceCode Financial Support

A263V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 2 5 7 – A 2 6 5

Page 8: ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

PRM56 NonePRM57 NonePRM58 NonePRM59 NonePRM60 NICE Decision Support Unit, Sheffield, UKPRM61 NonePRM62 NonePRM63 Universidad Nacional de Colombia, Bogota, ColombiaPRM64 NonePRM65 NonePRS1 NonePRS2 NonePRS3 NonePRS4 GlaxoSmithKline, RTP, NC, USAPRS5 NonePRS6 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPRS7 University Grants Commission, Government of India, New Delhi, IndiaPRS8 NonePRS9 University of Houston, Houston, TX, USAPRS10 University of Houston, Houston, TX, USAPRS11 MedImmune, Gaithersburg, MD, USAPRS12 LLC Boehringer Ingelheim, Moscow, RussiaPRS13 Novartis, Bogotá, ColombiaPRS14 Pfizer Pharmaceuticals, Inc., São Paulo, BrazilPRS15 Pfizer Pharmaceuticals, Inc., São Paulo, BrazilPRS16 NonePRS17 NonePRS18 MedImmune, Gaithersburg, MD, USAPRS19 Forest Research Institute, Jersey City, NJ, USAPRS20 Covidien, Mansfield, MA, USAPRS21 Pfizer Central America and the Caribbean, Escazu, Costa RicaPRS22 Novartis Pharmaceutical, Mexico City, MexicoPRS23 Pfizer Central Aamerica and the Caribbean, Escazú, Costa RicaPRS24 Pfizer Central America and the Caribbean, Escazú, Costa RicaPRS25 Ppfizer Central America and the Caribbean, Escazú, Costa RicaPRS26 Pfizer Ltd, Tadworth, UKPRS27 Novartis, Bogotá, ColombiaPRS28 Pfizer Inc., New York, NY, USAPRS29 Forest Research Institute, Jersey City, NJ, USAPRS30 Novartis company, East Hanover, NJ, USAPRS31 NonePRS32 NonePRS33 NonePRS34 Kantar Health, Princeton, NY, USAPRS35 GlaxoSmithKline UK Ltd, Uxbridge, UKPRS36 Pfizer Inc., New York, NY, USAPRS37 NonePRS38 Abbott, Princeton, NJ, USAPRS39 Mississippi Division of Medicaid, Jackson, MS, USAPRS40 NonePRS41 NonePRS42 GlaxoSmithKline, Rio de Janeiro, BrazilPRS43 Sunovion Pharmaceuticals, Inc., Marlborough, MA, USAPRS44 Department of Industrial Safety & Health (DISH), Gujarat Government,

Ahmedabad, IndiaPRS45 sanofi-aventis US, Bridgewater, NJ, USAPRS46 NonePRS47 NonePRS48 NonePRS49 Sunovion Pharmaceuticals, Marlborough, MA, USAPRS50 Express Scripts Inc., St Louis, MO, USAPRS51 NonePRS52 Nycomed, Constance, Germany; Merck Shire Dome, Hoddesdon, UKPRS53 Genentech, Inc., South San Francisco, CA, USAPRS54 NonePRS55 Foundation FNEGE, Paris, FrancePR1 NonePR2 Institute for Health Technology Studies, Washington, DC, USAPR3 NonePR4 NonePSS1 NonePSS2 Medicis, Scottsdale, AZ, USAPSS3 NonePSS4 Janssen Scientific Affairs, LLC, Horsham, PA, USAPSS5 NonePSS6 Alcon Farmacevtika LLC, Moscow, RussiaPSS7 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPSS8 Novartis Canada, Dorval, QC, CanadaPSS9 Beijing Novartis Pharma Co., Ltd., Beijing, ChinaPSS10 Novartis Pharmaceutical, Mexico City, MexicoPSS11 Pfizer Brasil, São Paulo, Brazil

PSS12 Pfizer Brasil, São Paulo, BrazilPSS13 Pfizer Brasil, São Paulo, BrazilPSS14 Pfizer Brasil, São Paulo, BrazilPSS15 Pfizer Brasil, São Paulo, BrazilPSS16 Allergan, Irvine, CA, USAPSS17 Basilea Pharmaceutica International Ltd., Basel, SwitzerlandPSS18 Amgen, Inc., Thousand Oaks, CA, USAPSS19 NonePSS20 NonePSS21 Janssen Global Services, LLC, West Hills, CA, USAPSS22 NonePSS23 NonePSS24 NonePSS25 LEO Pharma, Ballerup, DenmarkPSS26 Janssen Scientific Affairs, LLC, Horsham, PA, USAPSS27 Janssen Scientific Affairs, LLC, Horsham, PA, USAPSS28 Austrian Society of ophthalmologic surgeons, Vienna, AustriaPSS29 Janssen Scientific Affairs, LLC, Horsham, PA, USAPSS30 Janssen Scientific Affairs, LLC, Horsham, PA, USAPSS31 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPSS32 Alcon Farmacevtika LLC, Moscow, RussiaPSS33 NonePSU1 Grunenthal, Stokenchurch, UKPSU2 NonePSU3 Ethicon Endo-Surgery, Inc., Cincinnati, OH, USAPSU4 Agency for Healthcare Research and Quality, Rockville, MD, USAPSU5 NonePSU6 Merck&Co. Inc., Whitehouse Station, NJ, USAPSU7 Alberta Health and Wellness, Edmonton, AB, CanadaPSU8 Eli Lilly and Co., Indianapolis, IN, USAPSU9 NonePSU10 Paradigm Spine, LLC, New York, NY, USAPSU11 Ethicon Endo-Surgery, Inc., Cincinnati, OH, USAPSU12 Ethicon Endo-Surgery, Inc, Cincinnati, OH, USAPSU13 NonePSU14 Ethicon, Inc, Somerville, NJ, USAPSU15 NonePSU16 Baxter Bio Surgery, Deerfield, IL, USAPSU17 Covidien, Mansfield, MA, USAPSU18 Covidien, Mansfield, MA, USAPSU19 NonePSU20 Covidien, Mansfield, MA, USAPSU21 Eli Lilly and Company, Indianapolis, IN, USAPSU22 Department of Health, Taipei, TaiwanPSU23 NonePSU24 NonePSU25 National Evidence-based Healthcare Collaborating Agency, Seoul, South

KoreaPSU26 National Evidence-based Healthcare Collaborating Agency, Seoul, South

KoreaPSU27 Eli Lilly and Company, Indianapolis, IN, USAPSU28 Johnson&Johnson Medical Brasil, Sao Paulo, BrazilPSU29 Johnson & Johnson Medical Brasil, Sao Paulo, BrazilPSU30 Medtronic Spine & Biologics, Minneapolis, MN, USAPSU31 National Evidence-based Healthcare Collaborating Agency, Seoul, South

KoreaPSU32 NonePSU33 NonePSU34 Allergan, Inc., Irvine, CA, USAPSU35 CHRISP, Queensland Health, Brisbane, AustraliaPSU36 NonePSU37 NonePSU38 NonePSU39 Ethicon endo-Surgery, Inc., Cincinnati, OH, USAPSU40 NonePSU41 NonePSY1 NonePSY2 GlaxoSmithKline, Research Triangle Park, NC, USA; Human Genome

Sciences, Rockville, MD, USAPSY3 NonePSY4 Celgene Corporation, Summit, NJ, USAPSY5 NonePSY6 Purdue Pharma LP, Stamford, CT, USAPSY7 Viforpharma, Neuilly sur Seine, FrancePSY8 NonePSY9 Pfizer Inc, New York, NY, USAPSY10 MedImmune, Inc., Gaithersburg, MD, USA; Thomson Reuters, Washington,

DC, USAPSY11 Pfizer, Inc., New York, NY, USAPSY12 Janssen Global Services, LLC, Raritan, NJ, USAPSY13 UCB, Atlanta, GA, USA

ReferenceCode Financial Support

ReferenceCode Financial Support

A264 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 2 5 7 – A 2 6 5

Page 9: ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

PSY14 Eli Lilly and Company, Indianapolis, IN, USAPSY15 Novo Nordisk, Soeberg, DenmarkPSY16 NonePSY17 Celgene Corporation, Summit, NJ, USAPSY18 Celgene Corporation, Summit, NJ, USAPSY19 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPSY20 Novo Nordisk Inc, Princeton, NJ, USAPSY21 Depomed, Inc., Menlo Park, CA, USAPSY22 Janssen Scientific Affairs, LLC, Horsham, PA, USAPSY23 Novartis Pharmaceuticals, East Hanover, NJ, USAPSY24 1 Janssen Scientific Affairs, LLC , Horsham, PA, USAPSY25 GlaxoSmithKline, Research Triangle Park, NC, USAPSY26 NonePSY27 NonePSY28 Pfizer S.A. de C.V., Ciudad de MMéexico, MexicoPSY29 Novo Nordisk A/S, Soborg, DenmarkPSY30 Pfizer S.A. de C.V., Ciudad de MMéexico, MexicoPSY31 Pfizer Korea, Seoul, South KoreaPSY32 Pfizer S.A. de C.V., Ciudad de MMéexico, MexicoPSY33 BMS, Bogota, ColombiaPSY34 Sanofi-Aventis, Surrey, UK; Pfizer, Surrey, UK; Universidad de Costa Rica,

San José, Costa RicaPSY35 Genesis Pharma Hellas, Athens, GreecePSY36 Pfizer Pharmaceuticals, Inc., São Paulo, BrazilPSY37 Bristol-Myers Squibb, Uxbridge, London, UKPSY38 Bristol-Myers Squibb, Uxbridge, London, UKPSY39 Janssen Scientific Affairs, LLC, Horsham, PA, USAPSY40 Astellas Pharma Global Development, Leiderdorp, NetherlandsPSY41 Forest Laboratories, Jersey City, NJ, USAPSY42 Millennium Pharmaceuticals, Inc., Cambridge, MA, USAPSY43 Janssen Scientific Services, LLC, Horsham, PA, USAPSY44 Janssen Scientific Services, LLC, Horsham, PA, USAPSY45 Janssen Scientific Services, LLC, Horsham, PA, USAPSY46 Pfizer Pharmaceuticals, Inc., São Paulo, BrazilPSY47 NonePSY48 Purdue Pharma L.P., Stamford, CT, USAPSY49 NonePSY50 NonePSY51 Express Scripts Inc., St. Louis, MO, USAPSY52 NonePSY53 Endo Pharmaceuticals, Chadds Ford, PA, USAPSY54 GlaxoSmithKline, Rio de Janeiro, BrazilPSY55 PriceSpective LLC, El Segundo, CA, USAPSY56 Glaxosmithkline, Research Triangle Park, NC, USA; Human Genome Science,

Rockville, MD, USAPSY57 Janssen Scientific Affairs, LLC, Horsham, PA, USAPSY58 Janssen Scientific Affairs, LLC, Horsham, PA, USAPSY59 Celgene Corporation, Summit, NJ, USAPSY60 PFSA, Boulogne Billancourt, FrancePSY61 Amgen Inc., Thousand Oaks, CA, USAPSY62 Eli Lilly and Company, Inc., Indianapolis, IN, USAPSY63 Eli Lilly and Company, Inc., Indianapolis, IN, USAPSY64 Bayer HealthCare Pharmaceuticals, Inc., Wayne, NJ, USAPSY65 NonePSY66 Baxter, Deerfield, IL, USAPSY67 QualityMetric Inc., Lincoln, RI, USAPSY68 Baxter BioScience , Deerfield, IL, USAPUK1 None

PUK2 DaVita Clinical Research, Minneapolis, MN, USAPUK3 NonePUK4 Takeda Pharmaceuticals, Deerfield, IL, USA; University of Southern

California, Los Angeles, CA, USAPUK5 Astellas Pharma Europe Ltd., Staines, UKPUK6 NonePUK7 University of Cincinnati Research Council, Cincinnati, OH, USAPUK8 Allergan, LLC, Irvine, CA, USAPUK9 Sanofi, Bridgewater, NJ, USAPUK10 Baxter Healtchcare Corporation, McGaw Park, IL, USAPUK11 Janssen Scientific Affairs, LLC, Horsham, PA, USAPUK12 Janssen Scientific Affairs, LLC, Horsham, PA, USAPUK13 NonePUK14 Vifor France SA, Neuilly sur Seine, FrancePUK15 Keryx Biopharmaceuticals, New York, NY, USAPUK16 Keryx Biopharmaceuticals, New York , NY, USAPUK17 Eli Lilly and Company, Indianapolis, IN, USAPUK18 Astellas, Deerfield, IL, USAPUK19 NonePUK20 Pfizer S.A. de C.V., Ciudad de MMéexico, MexicoPUK21 Astellas Pharma Europe Ltd., Staines, UKPUK22 Siriraj Research Development Fund (Managed by Routine to Research: R2R),

Mahidol University, Bangkok, ThailandPUK23 Astellas, Staines, UKPUK24 Janssen Scientific Affairs, LLC, Horsham, PA, USAPUK25 Drug Information Association Philanthropic Award, Horsham, PA, USAPUK26 Janssen Scientific Affairs, LLC, Horsham, PA, USAPUK27 Siriraj Research Development Fund (Managed by Routine to Research: R2R),

Mahidol University, Bangkok, ThailandPUK28 NonePUK29 Affymax, Palo Alto, CA, USA; DaVita Clinical Research, Minneapolis, MN,

USAPUK30 Affymax, Palo Alto, CA, USA; DaVita Clinical Research, Minneapolis, MN,

USAPUK31 Eli Lilly, Indianapolis, IN, USAPUK32 Affymax, Palo Alto, CA, USA; DaVita Clinical Research, Minneapolis, MN,

USAPUK33 Hemedicus, Incorporated, New York, NY, USAPUK34 Abbott Laboratories, Abbott Park, IL, USAPUK35 R2R SirirHospital, Bangkok, ThailandPUK36 John Ware Research Group, Worcester, MA, USAQU1 QualityMetric Incorporated, Lincoln, RI, USAQU2 Eli Lilly & Company, Indianapolis, IN, USAQU3 Leo Pharma, Parsippany, NJ, USAQU4 NoneRM1 Mayo Clinic Diabetes Center Pilot and Feasibility Award, Rochester, MN, USARM2 Novartis, East Hanover, NJ, USARM3 Agency for Healthcare Research And Quality, Rockville, MD, USARM4 Mallinkrodt Inc., a Covidien Company, Hazelwood, MO, USASB1 Eli Lilly and Company, Indianapolis, IN, USASB2 Centers for Medicare and Medicaid Services (CMS), Baltimore, MD, USASB3 GlaxoSmithKline, Research Triangle Park, NC, USASB4 Cubist Pharmaceuticals Inc., Lexington, MA, USAUT1 NoneUT2 NoneUT3 NoneUT4 None

ReferenceCode Financial Support

ReferenceCode Financial Support

A265V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 2 5 7 – A 2 6 5